A newly published Danish study has evaluated the efficacy and safety of CoreTherm® in men with prostate sizes exceeding 100 grams. The median prostate size among participants was 126 g (range: 101–230 g). The results demonstrate that more than 80% of patients experiencing urinary retention, requiring either an indwelling catheter or self-catheterization, were able to urinate spontaneously at the six-month follow-up after treatment.
The authors conclude that CoreTherm® provides a satisfactory effect in the majority of treated patients and that the findings suggest that CoreTherm® is a safe and effective treatment option for men with significantly enlarged prostates.